Castle Biosciences (CSTL) Goodwill & Intangibles (2018 - 2026)

Castle Biosciences (CSTL) has 7 years of Goodwill & Intangibles data on file, last reported at $97.3 million in Q1 2026.

• Quarterly Goodwill & Intangibles rose 24.96% year-over-year to $97.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.3 million (up 24.96% YoY) and the FY2025 annual result came in at $99.6 million, down 6.26% from the prior year.
• Goodwill & Intangibles declined to $97.3 million in Q1 2026 per CSTL's latest filing, from $99.6 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $132.7 million in Q2 2022, with the low at $77.9 million in Q1 2025.
• Average Goodwill & Intangibles over 5 years is $110.9 million, with a median of $112.8 million recorded in 2024.
• Year-over-year, Goodwill & Intangibles soared 306.05% in 2022 and tumbled 32.31% in 2025.
• Castle Biosciences' Goodwill & Intangibles stood at $126.3 million in 2022, then decreased by 7.13% to $117.3 million in 2023, then dropped by 9.47% to $106.2 million in 2024, then declined by 6.26% to $99.6 million in 2025, then declined by 2.24% to $97.3 million in 2026.
• Business Quant data shows CSTL's Goodwill & Intangibles at $97.3 million in Q1 2026, $99.6 million in Q4 2025, and $101.8 million in Q3 2025.